Skip to main content
Clinical Trials/NCT00752440
NCT00752440
Unknown
Phase 4

Inspiratory Muscle Training in Patients With Autonomic Neuropathic: a Randomized Trial

Instituto de Cardiologia do Rio Grande do Sul1 site in 1 country24 target enrollmentAugust 2006

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Diabetes Mellitus
Sponsor
Instituto de Cardiologia do Rio Grande do Sul
Enrollment
24
Locations
1
Primary Endpoint
Inspiratory muscle strength
Last Updated
17 years ago

Overview

Brief Summary

This study describes a controlled randomized clinical trial to evaluate the effect of inspiratory muscle training in patients with diabetic autonomic neuropathy.

Detailed Description

The diabetic autonomic neuropathy (NAD) is a common complication of diabetes mellitus (DM), both of the type 1 diabetes mellitus (DM1) as of the type 2 diabetes mellitus (DM2). The results of this study, would help to reveal the degree of commitment generated by NAD in respiratory muscle strength, can also enable the development of a new therapeutic approach, such non-pharmacological (respiratory muscle training), with a view to improve the respiratory muscle strength and alleviate the autonomic dysfunction in these patients.

Registry
clinicaltrials.gov
Start Date
August 2006
End Date
July 2009
Last Updated
17 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Instituto de Cardiologia do Rio Grande do Sul

Eligibility Criteria

Inclusion Criteria

  • Diabetic autonomic neuropathy
  • Age between 36 and
  • 70 years old and signed in informed consent form

Exclusion Criteria

  • Presence of congestive heart failure
  • Chronic obstructive pulmonary disease (FEV1 \< 70% and/or FEV1%\< 80
  • Class II or III obesity (body mass index \> 35)

Outcomes

Primary Outcomes

Inspiratory muscle strength

Time Frame: eight

Secondary Outcomes

  • Variability of heart rate(eight)

Study Sites (1)

Loading locations...

Similar Trials